{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:04:30Z","timestamp":1764259470126},"reference-count":55,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2003,2,1]],"date-time":"2003-02-01T00:00:00Z","timestamp":1044057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2003,2]]},"DOI":"10.1067\/mai.2003.92","type":"journal-article","created":{"date-parts":[[2003,4,24]],"date-time":"2003-04-24T00:57:16Z","timestamp":1051145836000},"page":"S659-S668","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S2","title":["20. Immunologic neuromuscular disorders"],"prefix":"10.1067","volume":"111","author":[{"given":"Tanuja","family":"Chitnis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia J.","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1067\/mai.2003.92_bib1","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1067\/mai.2003.92_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S0317167100047351","article-title":"Epidemiology of multiple sclerosis: a critical overview","volume":"20","author":"Sadovnick","year":"1993","journal-title":"Can J Neurol Sci"},{"key":"10.1067\/mai.2003.92_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2003.92_bib4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1172\/JCI1528","article-title":"Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients: a marker of activated\/memory T cells","volume":"101","author":"Lovett-Racke","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1067\/mai.2003.92_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/346183a0","article-title":"T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis","volume":"346","author":"Ota","year":"1990","journal-title":"Nature"},{"key":"10.1067\/mai.2003.92_bib7","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.410370404","article-title":"The adhesion molecule and cytokine profile of multiple sclerosis lesions","volume":"37","author":"Cannella","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(87)92863-7","article-title":"Exacerbations of multiple sclerosis in patients treated with gamma interferon","volume":"1","author":"Panitch","year":"1987","journal-title":"Lancet"},{"key":"10.1067\/mai.2003.92_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0165-5728(01)00371-X","article-title":"Increased percentage of IL-12+ monocytes in the blood correlates with the presence of active MRI lesions in MS","volume":"119","author":"Makhlouf","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1067\/mai.2003.92_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1073\/pnas.94.2.599","article-title":"Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand","volume":"94","author":"Balashov","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1067\/mai.2003.92_bib11","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI200112563","article-title":"Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis","volume":"108","author":"Chitnis","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1067\/mai.2003.92_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.186.2.307","article-title":"Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease","volume":"186","author":"Lafaille","year":"1997","journal-title":"J Exp Med"},{"key":"10.1067\/mai.2003.92_bib13","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2003.92_bib14","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1056\/NEJM198612253152603","article-title":"A population-based study of multiple sclerosis in twins","volume":"315","author":"Ebers","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2003.92_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/ng0896-469","article-title":"A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group","volume":"13","author":"Haines","year":"1996","journal-title":"Nat Genet"},{"key":"10.1067\/mai.2003.92_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib17","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.53.8.1698","article-title":"Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group","volume":"53","author":"Rudick","year":"1999","journal-title":"Neurology"},{"key":"10.1067\/mai.2003.92_bib18","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(98)03334-0","article-title":"Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing\/remitting multiple sclerosis","volume":"352","author":"PRISMS Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis Study Group","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/mai.2003.92_bib19","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1212\/WNL.43.4.655","article-title":"Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"43","author":"The IFNB Multiple Sclerosis Study Group","year":"1993","journal-title":"Neurology"},{"key":"10.1067\/mai.2003.92_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.410390304","article-title":"Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis","volume":"39","author":"Jacobs","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib21","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4049\/jimmunol.165.1.548","article-title":"IFN-beta-1b inhibits IL-12 production in peripheral blood mononuclear cells in an IL-10-dependent mechanism: relevance to IFN-beta-1b therapeutic effects in multiple sclerosis","volume":"165","author":"Wang","year":"2000","journal-title":"J Immunol"},{"key":"10.1067\/mai.2003.92_bib22","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1212\/WNL.46.6.1633","article-title":"Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis","volume":"46","author":"Brod","year":"1996","journal-title":"Neurology"},{"key":"10.1067\/mai.2003.92_bib23","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/ana.410410517","article-title":"Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b","volume":"41","author":"Calabresi","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1172\/JCI8970","article-title":"Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis","volume":"105","author":"Duda","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1067\/mai.2003.92_bib25","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/WNL.45.7.1268","article-title":"Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial","volume":"45","author":"Johnson","year":"1995","journal-title":"Neurology"},{"key":"10.1067\/mai.2003.92_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1191\/1352458502ms790oa","article-title":"Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects","volume":"8","author":"Weiner","year":"2002","journal-title":"Mult Scler"},{"key":"10.1067\/mai.2003.92_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-5728(98)00125-8","article-title":"Myelin basic protein reactive Th2 T cells are found in acute disseminated encephalomyelitis","volume":"91","author":"Pohl-Koppe","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1067\/mai.2003.92_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib29","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1093\/brain\/119.6.2053","article-title":"The prognosis and main prognostic indicators of Guillain-Barre syndrome. A multicentre prospective study of 297 patients","volume":"119","author":"The Italian Guillain-Bare Study Group","year":"1996","journal-title":"Brain"},{"key":"10.1067\/mai.2003.92_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.410390512","article-title":"Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy","volume":"39","author":"Hafer-Macko","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib31","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/WNL.51.2.371","article-title":"Campylobacter jejuni lipopolysaccharides in Guillain-Barr\u00e9 syndrome: molecular mimicry and host susceptibility","volume":"51","author":"Sheikh","year":"1998","journal-title":"Neurology"},{"key":"10.1067\/mai.2003.92_bib32","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/mus.880171004","article-title":"Autonomic involvement in Guillain-Barr\u00e9 syndrome: a review","volume":"17","author":"Zochodne","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1067\/mai.2003.92_bib33","first-page":"339","article-title":"Guillain-Barr\u00e9 syndrome: clinical neurophysiologic studies","volume":"152","author":"Cros","year":"1996","journal-title":"Rev Neurol (Paris)"},{"key":"10.1067\/mai.2003.92_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0140-6736(96)09095-2","article-title":"Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barr\u00e9 syndrome","volume":"349","author":"Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/mai.2003.92_bib35","first-page":"586","article-title":"Double-blind trial of intravenous methylprednisolone in Guillain-Barr\u00e9 syndrome","volume":"341","author":"Guillain-Barr\u00e9 Syndrome Steroid Trial Group","year":"1993","journal-title":"Lancet"},{"key":"10.1067\/mai.2003.92_bib36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","article-title":"Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: a double-blind, sham-controlled, cross-over study","volume":"119","author":"Hahn","year":"1996","journal-title":"Brain"},{"key":"10.1067\/mai.2003.92_bib37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1600-0404.1995.tb00432.x","article-title":"Associated autoimmune diseases in myasthenia gravis: a population-based study","volume":"91","author":"Christensen","year":"1995","journal-title":"Acta Neurol Scand"},{"key":"10.1067\/mai.2003.92_bib38","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.4049\/jimmunol.153.7.3353","article-title":"Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes","volume":"153","author":"Yi","year":"1994","journal-title":"J Immunol"},{"key":"10.1067\/mai.2003.92_bib39","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/ana.410410609","article-title":"Altered intrathymic T-cell repertoire in human myasthenia gravis","volume":"41","author":"Truffault","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib40","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1212\/WNL.38.4.514","article-title":"Seronegative myasthenia gravis","volume":"38","author":"Soliven","year":"1988","journal-title":"Neurology"},{"key":"10.1067\/mai.2003.92_bib41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/(SICI)1097-4598(199609)19:9<1069::AID-MUS1>3.0.CO;2-Y","article-title":"AAEM minimonograph #25: single-fiber electromyography","volume":"19","author":"Sanders","year":"1996","journal-title":"Muscle Nerve"},{"key":"10.1067\/mai.2003.92_bib42","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/jnnp.54.5.406","article-title":"Actuarial analysis of the occurrence of remissions following thymectomy for myasthenia gravis in 400 patients","volume":"54","author":"Durelli","year":"1991","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mai.2003.92_bib43","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ana.410410615","article-title":"Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis","volume":"41","author":"Gajdos","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib44","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199103283241303","article-title":"Polymyositis mediated by T lymphocytes that express the gamma\/delta receptor","volume":"324","author":"Hohlfeld","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2003.92_bib45","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198602063140601","article-title":"Microvascular deposition of complement membrane attack complex in dermatomyositis","volume":"314","author":"Kissel","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1067\/mai.2003.92_bib46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/304177a0","article-title":"Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity","volume":"304","author":"Mathews","year":"1983","journal-title":"Nature"},{"key":"10.1067\/mai.2003.92_bib47","first-page":"31","article-title":"Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis","volume":"141","author":"Askanas","year":"1992","journal-title":"Am J Pathol"},{"key":"10.1067\/mai.2003.92_bib48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1067\/mai.2003.92_bib49","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/art.1780390218","article-title":"Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis","volume":"39","author":"Vazquez-Abad","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1067\/mai.2003.92_bib50","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1097-4598(199706)20:6<651::AID-MUS1>3.0.CO;2-7","article-title":"Treatment of inflammatory myopathies","volume":"20","author":"Mastaglia","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1067\/mai.2003.92_bib51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp.65.1.107","article-title":"Immunoglobulin therapy in inflammatory myopathies","volume":"65","author":"Mastaglia","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mai.2003.92_bib52","first-page":"263","article-title":"Long-term prognosis of 69 patients with dermatomyositis or polymyositis","volume":"14","author":"Maugars","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1067\/mai.2003.92_bib53","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0049-0172(98)80052-8","article-title":"High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis","volume":"27","author":"Maoz","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1067\/mai.2003.92_bib54","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/brain\/120.8.1279","article-title":"Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome","volume":"120","author":"Mason","year":"1997","journal-title":"Brain"},{"key":"10.1067\/mai.2003.92_bib55","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1200\/JCO.1997.15.8.2866","article-title":"Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival","volume":"15","author":"Graus","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674902913540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674902913540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T04:13:13Z","timestamp":1704773593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674902913540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,2]]}},"alternative-id":["S0091674902913540"],"URL":"https:\/\/doi.org\/10.1067\/mai.2003.92","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2003,2]]}}}